Download PDF
Thromb Haemost 1997; 78(01): 151-160
DOI: 10.1055/s-0038-1657519
Molecular defects in rare bleeding disorders
Schattauer GmbH Stuttgart

Inherited Factor VII Deficiency: Molecular Genetics and Pathophysiology

David N Cooper
1   Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff
,
David S Millar
1   Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff
,
Adam Wacey
2   Thrombosis Research Institute, Manresa Road, London
,
David W Banner
3   Pharmaceuticals Division, F. Hoffmann-La Roche Ltd, Basel, Switzerland
,
Edward G D Tuddenham
4   Haemostasis Research Group, Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88: 1583-1587
    PubMedGoogle Scholar
  • 2 Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-744
    PubMedGoogle Scholar
  • 3 Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor VIIa in haemophilia A and B patients. Blood 1992; 80: 25-28
    PubMedGoogle Scholar
  • 4 Meade TW. Factor VII and ischaemic heart disease: epidemiologic evidence. Haemostasis 1983; 13: 178-185
    PubMedGoogle Scholar
  • 5 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 02: 533-537
    PubMedGoogle Scholar
  • 6 Ragni MV, Lewis JH, Spero JA, Hasiba U. Factor VII deficiency. Am J Hematol 1981; 10: 79-88
    CrossrefPubMedGoogle Scholar
  • 7 Mariani G, Mazzucconi MG, Hermans J, Ciavarella N, Faiella A, Hassan HJ, Mannucci PM, Nenci GG, Orlando M, Romoli D, Mandelli F. Factor VII deficiency: immunological characterization of genetic variants and detection of carriers. Br J Haematol 1981; 48: 07-14
    PubMedGoogle Scholar
  • 8 Triplett DA, Brandt JT, Batard MA, Dixon JS, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985; 66: 1284-1287
    PubMedGoogle Scholar
  • 9 Tuddenham EGD, Cooper DN. The Molecular Genetics of Haemostasis and its Inherited Disorders. Oxford University Press; Oxford: 1994
    Google Scholar
  • 10 Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities. Medicine 1983; 62: 248-255
    CrossrefPubMedGoogle Scholar
  • 11 Tuddenham EGD, Pemberton S, Cooper DN. Inherited factor VII deficiency: genetics and molecular pathology. Thromb Haemost 1995; 74: 313-321
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Wion KL, Kelly D, Summerfield JA, Tuddenham EGD, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 1985; 317: 726-729
    CrossrefPubMedGoogle Scholar
  • 13 Fair DS. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983; 62: 784-791
    PubMedGoogle Scholar
  • 14 Persson E, Nielsen LS. Site-directed mutagenesis but not g-carboxylation of Glu-35 in factor Vila affects the association with tissue factor. FEBS Letts 1996; 385: 241-243
    CrossrefPubMedGoogle Scholar
  • 15 Banner DW, D’Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D. The crystal structure oflhe complex of blood coagulation factor Vila with soluble tissue factor. Nature 1996; 380: 41-46
    CrossrefPubMedGoogle Scholar
  • 16 Butenas S, Mann KG. Kinetics of human factor VII activation. Biochemistry 1996; 35: 1904-1910
    CrossrefPubMedGoogle Scholar
  • 17 Iwanaga S, Nishimura H, Kawabata S, Kisiel W, Hase S, Ikenaka T. A new trisaccharide sugar chain linked to a serine residue in the first EGF-like domain of clotting factors VII and IX and protein Z. Adv Exp Med Biol 1990; 281: 121-131
    PubMedGoogle Scholar
  • 18 Bjoern S, Foster DC, Thim L, Wiberg FC, Christensen M, Komiyama Y, Pedersen AH, Kisiel W. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine. J Biol Chem 1991; 266: 11051-11057
    PubMedGoogle Scholar
  • 19 Thim L, Bjoern S, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor Vila from plasma and transfected baby hamster kidney cells. Biochemistry 1988; 27: 7785-7793
    CrossrefPubMedGoogle Scholar
  • 20 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 01-08
    PubMedGoogle Scholar
  • 21 Wildgoose P, Berkner KL, Kisiel W. Synthesis, purification and characterization of an Argl52->Gln site directed mutant of recombinant human blood clotting factor VII. Biochemistry 1990; 29: 3413-3420
    CrossrefPubMedGoogle Scholar
  • 22 Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor Vila: effects of calcium, phospholipids and tissue factor. Biochemistry 1990; 29: 9418-9425
    CrossrefPubMedGoogle Scholar
  • 23 Repke K, Gemmell CH, Guha A, Turitto VT, Broze GJ, Nemerson Y. Hemophilia as a defect of the tissue factor pathway of blood coagulation. Effect of factors VIII and IX on factor X activation in a continuous flow reactor. Proc Natl Acad Sci USA 1990; 87: 7623-7627
    CrossrefPubMedGoogle Scholar
  • 24 Eichinger S, Mannucci PM, Tradati F, Arbini AA, Rosenberg RD, Bauer KA. Determinants of plasma factor Vila levels in humans. Blood 1995; 86: 3021-3025
    PubMedGoogle Scholar
  • 25 Butenas S, Mann KG. Kinetics of human factor VII activation-(Biochemistry. 1996; 35: 1904-1910
    PubMedGoogle Scholar
  • 26 Rao LV, Williams T, Rapaport SI. Studies of the activation of factor VII bound to tissue factor. Blood 1996; 87: 3738-3748
    PubMedGoogle Scholar
  • 27 Harlos K, Martin DMA, O’Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EGD, Boys CWG. Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370: 662-666
    CrossrefPubMedGoogle Scholar
  • 28 Muller YA, Ultsch MH, Kelley RF, de VosAM. Structure of the extracellular domain of human tisue factor: location of the factor Vila binding site. Biochemistry 1994; 33: 10864-10870
    CrossrefPubMedGoogle Scholar
  • 29 Ruf W, Schullek JR, Stone MJ, Edgington TS. Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry 1994; 33: 1565-1572
    CrossrefPubMedGoogle Scholar
  • 30 Gibbs CS, McCurdy SN, Leung LLK, Paborsky LR. Identification of the factor Vila binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis. Biochemistry 1994; 33: 14003-14010
    CrossrefPubMedGoogle Scholar
  • 31 Dickinson CD, Kelly CR, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor Vila. Proc Natl Acad ci USA 1996; 93: 14379-14384
    PubMedGoogle Scholar
  • 32 Chang JY, Stafford DW, Straight DL. The roles of factor VII’s structural domains in tissue factor binding. Biochemistry 1995; 34: 12227-12232
    CrossrefPubMedGoogle Scholar
  • 33 McCallum CD, Hapak RC, Neuenschwander PF, Morrissey JH, Johnson AE. The location of the active site of blood coagulation factor Vila above the membrane surface and its reorientation upon association with tissue factor. Biol. Chem 1996; 271: 28168-28175
    PubMedGoogle Scholar
  • 34 Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDN A coding for human factor VII. Proc. Natl Acad Sci USA 1986; 83: 2412-2416
    CrossrefPubMedGoogle Scholar
  • 35 O’Hara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS, Murray MJ. Nucleotide sequence of the gene coding for human factor VII a vitamin K-dependent protein participating in blood coagulation. Proc. Natl Acad Sci USA 1987; 84: 5158-5162
    CrossrefPubMedGoogle Scholar
  • 36 Miao CH, Leytus SP, Chung DW, Davie EW. Liver-specific expression of the gene coding for human factor Xa blood coagulation factor. J Biol Chem 1992; 267: 7395-7401
    PubMedGoogle Scholar
  • 37 Berkner K, Busby S, Davie E, Hart C, Insley M, Kisiel W, Kumar A, Murray M, O’Hara P, Woodbury R, Hagen F. Isolation and expression of cDNAs encoding human factor VII. Cold Spring Harb. Symp Quant Biol 1986; 51: 531-541
    CrossrefPubMedGoogle Scholar
  • 38 Millar DS. unpublished results
    PubMed
  • 39 Brothers AB, Clarke BJ, Sheffield WP, Blajchman MA. Complete nucleotide sequence of the cDNA encoding rabbit coagulation factor VII. Thromb Res 1993; 69: 231-238
    CrossrefPubMedGoogle Scholar
  • 40 Idusogie E, Rosen E, Geng J-P, Carmeliet P, Collen D, Castellino FJ. Characterization of a cDNA encoding murine coagulation factor VII. Thromb Haemost 1996; 75: 481-487
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Murakawa M, Okamura T, Kamura T, Kuroiwa M, Harada M, Niho Y. Analysis of the partial nucleotide sequences and deuced primary structures of the protease domains of mammalian blood coagulation factors VII and X. Eur.J. Haematol 1994; 52: 162-168
    PubMedGoogle Scholar
  • 42 Idusogie E, Rosen ED, Carmeliet P, Collen D, Castellino FJ. Nucleotide structure and characterization of the murine blood coagulation factor VII gene. Thromb Haemost 199; 76: 957-964
    PubMedGoogle Scholar
  • 43 Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. Factor VII antigen levels in a healthy blood donor population. Thromb. Haemost 1994; 72: 21-27
    PubMedGoogle Scholar
  • 44 Scarabin P-Y, Vissac A-M, Kirzin J-M, Bourgeat P, Amiral J, Agher R, Guize L. Population correlates of coagulation factor VII. Arteriosler. Thromb Vase Biol 1996; 16: 1170-1176
    PubMedGoogle Scholar
  • 45 Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscl. Thromb 1991; 11: 540-546
    PubMedGoogle Scholar
  • 46 Lane A, Cruikshank JK, Stewart J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factorVII coagulant activity in different ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50
    CrossrefPubMedGoogle Scholar
  • 47 Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscl. Thromb 1994; 14: 193-198
    PubMedGoogle Scholar
  • 48 Silveria A, Green F, Karpe F, BlombÑck M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb. Haemost 1994; 72: 734-739
    PubMedGoogle Scholar
  • 49 Lane A, Green F, Humphries S, Ruddock V, Meade T. Effect of factor VII genotype on response to warfarin treatment. Thromb. Haemost 1995; 73: 325
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Meilahn E, Ferrell R, Kiss J, Temple A, Green F, Humphries S, Kuller L. Genetic determination of coagulation factor VII c levels among healthy middle-aged women. Thromb. Haemost 1995; 73: 623-625
    Article in Thieme ConnectPubMedGoogle Scholar
  • 51 Lane A, Green F, Scarabin PY, Nicaud V, Bara L, Humphries S, Evans A, Luc G, Cambou JP, Arveiler D, Cambien F. The factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis 1996; 119: 119-127
    CrossrefPubMedGoogle Scholar
  • 52 Kario K, Narita N, Matsuo T, Kayaba K, Tsutsumi A, Matsuo M, Miyata T, Shimada K. Genetic determinants of plasma factor VII activity in the Japanese. Thromb. Haemost 1995; 73: 617-622
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Heywood DM, Ossei-Geming N, Grant PJ. Association of factor VII:C levels with environmental and genetic factors in patients with ischaemic heart disease and coronary atheroma characterized by angiography. Thromb. Haemost 1996; 76: 161-165
    Article in Thieme ConnectPubMedGoogle Scholar
  • 54 Saha N, Liu Y, Heng CK, Hong S, Low PS, Tay JS. Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides. Arterioscl. Thromb 1994; 14: 1923-1927
    PubMedGoogle Scholar
  • 55 Takamiya O. Genetic polymorphism (Arg353iEGln) in coagulation factor VII gene and factor VII levels (coagulant activity, antigen and binding ability to tissue factor) in 101 healthy Japanese. Scand J. Clin Lab Invest 1995; 55: 211-215
    CrossrefPubMedGoogle Scholar
  • 56 Arbini AA, Bauer KA. Reduced plasma factor VII coagulant activity due to the Aig353Gln polymorphism in the factor VII gene results from defective secretion. Blood 1994; 84 (Suppl. 01) 86a
    PubMedGoogle Scholar
  • 57 Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in different ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50
    CrossrefPubMedGoogle Scholar
  • 58 Humphries SE, Lane A, Green F, Cooper J, Miller G. Factor VII coagulant activity and antigen levels in men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscl. Thromb 1994; 14: 193-198
    PubMedGoogle Scholar
  • 59 Koster T, Rosendaal FR, Reitsma PH, van derVelden PA, Briët E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. Thromb. Haemost 1994; 71: 719-722
    Article in Thieme ConnectPubMedGoogle Scholar
  • 60 Escoffre M, Zini JM, Schliamser L, Mazoyer E, Soria C, Tobelem G, Dupuy E. Severe arterial thrombosis in a congenitally factor VII deficient patient. Br J Haematol 1995; 91: 739-741
    CrossrefPubMedGoogle Scholar
  • 61 Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5’ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet 1993; 90: 575-576
    CrossrefPubMedGoogle Scholar
  • 62 Sacchi E, Tagliabue L, Scoglio R, Baroncini C, Coppola R, Bernardi F, Mannucci PM. Plasma factor VII levels are influenced by a polymorphism in the promoter region of the FVII gene. Blood Coag. Fibrinol 1996; 07: 114-117
    PubMedGoogle Scholar
  • 63 Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb. Haemost 1996; 75: 567-572
    PubMedGoogle Scholar
  • 64 Pollak ES, Hung HL, Godin W, Overton GC, High KA. Functional characterization of the human factor VII 5’-flanking region. J Biol Chem 1996; 271: 1738-1747
    CrossrefPubMedGoogle Scholar
  • 65 Erdmann D, Heim J. Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter. J Biol Chem 1995; 270: 22988-22996
    CrossrefPubMedGoogle Scholar
  • 66 Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, Chiarotti F, Mariani G. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler. Thromb Vase Biol 1996; 16: 72-76
    PubMedGoogle Scholar
  • 67 Temple A, Luong LA, Cruickshank K, Humphries SE. The 10-base-pair insertion in the promoter of the factor VII gene is not associated with lower levels of factor VIIC in Afrocarribeans. Thromb. Haemost 1997; 77: 213-214
    Article in Thieme ConnectPubMedGoogle Scholar
  • 68 O’Hara PJ, Grant FJ. The human factor VII gene is polymorphic due to variation in repeat copy number in a minisatellite. Gene 1988; 66: 147-158
    CrossrefPubMedGoogle Scholar
  • 69 Marchetti G, Gemmati D, Patracchini P, Pinotti M, Bernardi F. PCR detection of a repeat polymorphism within the F7 gene. Nucleic Acids Res 1991; 19: 4570
    PubMedGoogle Scholar
  • 70 de KnijffP, Green F, Johansen LG, Grootendorst D, Temple A, Cruickshank JK, Humphries SE, Jespersen J, Kluft C. New alleles in F7 VNTR. Hum Molec. Genet 1994; 03: 384
    PubMedGoogle Scholar
  • 71 Chaing SH, Wallmark A, Berntorp E, High KA. A NIaIII polymorphism within the human factor VII gene.Hum. Genet 1994; 93: 722-723
    PubMedGoogle Scholar
  • 72 Hassan HJ, Leonardi A, Chelucci C, Mattia G, Macioce G, Guerriero R, Russo G, Mannucci PM, Peschle C. Blood coagulation factors in human embryonic fetal development: preferential expression of the FVII/tissue factor pathway. Blood 1990; 76: 1158-1164
    PubMedGoogle Scholar
  • 73 Hassan HJ, Chelucci C, Peschle C, Sorrentino V. Transforming growth factor b inhibits expression of fibrinogen and factor VII in a hepatoma cell line. Thromb. Haemost 1992; 67: 478-483
    Article in Thieme ConnectPubMedGoogle Scholar
  • 74 Greenberg D, Miao CH, Ho WT, Chung DW, Davie EW. Liver-specific expression of the human factor VII gene. Proc Natl Acad Sci USA 1995; 92: 12347-12351
    CrossrefPubMedGoogle Scholar
  • 75 Cooper DN, Krawczak M. Human Gene Mutation. Bios Scientific. Oxford: 1993
    Google Scholar
  • 76 McVey JH, Takamiya O, Tamagnini G, Valente V, Fidalgo T, Layton M, Tuddenham EGD. Exclusion of the first EGF domain of factor VII by a splice site mutation causes lethal factor VII deficiency. Thromb. Haemost 1995; 73: 1439
    PubMedGoogle Scholar
  • 77 Tamary H, Fromovitch Y, Shalmon L, Reich Z, Dym O, Lanir N, Brenner B, Paz M, Luder AS, Blau O, Korostishevsky M, Zaizov R, Seligsohn U. Ala 244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews. Thromb. Haemost 1996; 76: 283-291
    Article in Thieme ConnectPubMedGoogle Scholar
  • 78 Bemardi F, Patracchini P, Gemmati D, Ferrati M, Arcieri P, Papacchini M, Redaelli R, Baudo F, Mariani G, Marchetti G. Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region. Hum. Genet 1993; 92: 446-450
    PubMedGoogle Scholar
  • 79 Bernardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Redaelli R, Ballerini G, Pemberton S, Wacey AI, Mariani G, Tuddenham EGD, Marchetti G. Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br J Haematol 1994; 86: 610-618
    CrossrefPubMedGoogle Scholar
  • 80 Marchetti G, Patracchini P, Gemmati D, DeRosa V, Pinotti M, Rodorigo G, Casonato A, Girolami A, Bemardi F. Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7). Hum. Genet 1992; 89: 497-502
    PubMedGoogle Scholar
  • 81 Bemardi F, Castaman G, Pinotti M, Ferraresi P, Di IasioMG, Lunghi B, Rodeghiero F, Marchetti G. Mutation pattern in clinically asymptomatic coagulation factor VII deficiency. Hum. Mutation 1996; 08: 108-115
    PubMedGoogle Scholar
  • 82 O’Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EGD. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991; 78: 132-140
    CrossrefPubMedGoogle Scholar
  • 83 Millar DS, Cooper DN, Kakkar VV, Schwartz M, Scheibel E. Prenatal exclusion of severe factor VII deficiency by DNA sequencing. Lancet 1992; 339: 1359
    PubMedGoogle Scholar
  • 84 AlShinawi C, Scerri C, Galdies R, Aquilina A, Felice AE. Two new missense mutations (P134T and A244V) in the the coagulation factor VII gene. Hum. Mutation 1997 in press
    PubMedGoogle Scholar
  • 85 Giannelli F, Green PM, Sommer SS, Poon M-C, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG. Haemophilia B (sixth edition): a database of point mutations and short additions and deletions. Nucleic Acids Res 1996; 24: 103-118
    CrossrefPubMedGoogle Scholar
  • 86 Grundy CB, Melissari E, Lindo V, Scully MF, Kakkar VV, Cooper DN. Late-onset homozygous protein C deficiency. Lancet 1991; 338: 575-576
    PubMedGoogle Scholar
  • 87 Padmanabham K, Padmanabham KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT, Cardin AD, Kisiel W. Structure of human des(1045) factor Xa at 2.2è resolution. J Molec Biol 1993; 232: 947-966
    CrossrefPubMedGoogle Scholar
  • 88 Bharadwaj D, lino M, Kontoyianni M, Smith KJ, Foster DC, Kisiel W. Factor VII Central. J Biol Chem 1996; 271: 30685-30691
    CrossrefPubMedGoogle Scholar
  • 89 Arbini AA, Mannucci PM, Bauer KA. A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood 1996; 87: 5085-5094
    PubMedGoogle Scholar
  • 90 Arbini AA, Pollak ES, Bayleran JK, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter. Blood 1997; 89: 176-182
    CrossrefPubMedGoogle Scholar
  • 91 Kavlie A, Wright MS, Stormorken H, Prydz H. Mutations in the factor VII gene of Norwegian FVII deficient patients. Thromb. Haemost 1993; 69: 612
    PubMedGoogle Scholar
  • 92 Rosa H, Diniz MJ, Lavinha J. Factor VII Coimbra: a novel splice site mutation in the human factor VII gene. Eur J Hum Genet 1996; 04 (Suppl. 01) 72
    PubMedGoogle Scholar
  • 93 Chen Q, Clarke BJ, Blajchman MA, Ofusu FA. Factor VII Hamilton: a novel type 2 mutation located at residue 57 in the first EGF domain of human factor VII. Thromb. Haemost 1993; 69: 1291
    PubMedGoogle Scholar
  • 94 Chaing S, Clarke B, Sridhara S, Chu K, Friedman P, VanDusen W, Roberts HR, Blajchman M, Monroe DM, High KA. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor. Blood 1994; 83: 3524-3535
    PubMedGoogle Scholar
  • 95 Takamiya O, Abe S, Yoshioka A, Nakajima K, McVey JH, Tuddenham EGD. Factor VII Shinjo: a dysfunctional factor VII variant homozygous for the substitution Gin for Arg at position 79. Haemostasis 1995; 25: 89-97
    PubMedGoogle Scholar
  • 96 Takamiya O, Kemball-Cook G, Martin DMA, Cooper DN, von FeltenA, Meili E, Hann I, Prangnell DR, Lumley H, Tuddenham EGD, McVey JH. Detection of missense mutations by single-strand conformational polymorphism (SSCP) analysis in five dysfunctional variants of coagulation factor VII. Hum. Molec Genet 1993; 02: 1355-1359
    PubMedGoogle Scholar
  • 97 Kuppuswamy MN, Sabharwal AK, Birktoft JJ, Bajaj SP. Molecular characterization of human factor VII Kansas (GK704): substitution of GlnlOO by Arg in one allele and of Arg304 by Gin possibly in the other allele. Thromb. Haemost 1993; 69: 1292
    PubMedGoogle Scholar
  • 98 Marchetti G, Ferrati M, Patracchini P, Redaelli R, Bernardi F. A missense mutation (178Cys-»Tyr) and two neutral dimorphisms (115His and 333Ser) in the human coagulation factor VII gene. Hum. Molec Genet 1993; 02: 1055-1056
    PubMedGoogle Scholar
  • 99 Bernardi F, Castaman G, Redaelli R, Pinotti M, Lunghi B, Rodeghiero F, Marchetti G. Topologically equivalent mutations causing dysfunctional coagulation factors VII (294Ala->Val) andX (334Ser→Pro). Hum. Molec Genet 1994; 03: 1175-1177
    PubMedGoogle Scholar
  • 100 Ohiwa M, Hayashi T, Wada H, Minamikawa K, Shirakawa S, Suzuki K. Factor VII Mie: homozygous asymptomatic type I deficiency caused by an amino acid substitution of His (CAC) for Arg (247) (CGC) in the catalytic domain. Thromb. Haemost 1994; 71: 773-777
    Article in Thieme ConnectPubMedGoogle Scholar
  • 101 Arbini AA, Bodkin D, Lopaciuk S, Bauer KA. Molecular analysis of Polish patients with factor VII deficiency. Blood 1994; 84: 2214-2220
    PubMedGoogle Scholar
  • 102 James HL, Girolami A, Hubbard JG, Kumar A, Fair DS. The dysfunction of coagulation factor VII Padua results from substitution of arginine 304 by glutamine. Biochim. Biophys Acta 1993; 1172: 301-305
    PubMedGoogle Scholar
  • 103 Matsushita T, Kojima T, Emi N, Takahashi I, Saito H. Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya (Arg304-»Trp). J Biol Chem 1994; 269: 7355-7363
    PubMedGoogle Scholar
  • 104 Zheng D-O, Shurafa M, James HL. Factor VII G331D: a variant molecule involving replacement of a residue in the substrate-binding region of the catalytic domain. Blood Coag. Fibrinol 1996; 07: 93-96
    PubMedGoogle Scholar